About TVM Capital Life Science
TVM Capital Life Science is a Financial Services company based in Munchen (Germany). Capital is invested in life science innovations for healthcare transformation. It operates on a Commission-Based model. TVM Capital Life Science has completed 2 acquisitions, including AMECOGroup and Amecath. TVM Capital Life Science offers products and services including Venture Capital Investment and Portfolio Company Support. Its focus areas include Finance, Venture Capital and Life Sciences Investment.
Company details
Funding is provided by TVM Capital Life Science to support novel and disruptive life science innovations. Focus is placed on early-stage therapeutics, commercial-stage medtech, diagnostics, and digital health products. Investments are made to develop and market breakthrough therapies and medical products benefiting patients and the healthcare system. A two-pronged strategy is employed, including financing through single asset companies in partnership with Eli Lilly and Company, and investing in late-stage therapeutics. Close collaboration with portfolio companies is maintained to build value and enable market leadership in their segments.
- Headquarters Munchen, Germany
- SectorsFinancial Services
- Email••••••••
- Phone•••• ••••
- Website tvm-capital.com
- Social LinkedIn X
- Investments & AcquisitionsAMECOGroup
& 1 more
Products & Services of TVM Capital Life Science
TVM Capital Life Science offers a comprehensive portfolio of products and services, including Venture Capital Investment and Portfolio Company Support.
Capital is provided for life science innovations development.
Expertise is offered to grow life science companies.
People of TVM Capital Life Science
14 people are tracked at TVM Capital Life Science (6 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Luc Marengère | Managing Partner | Leadership |
Hoffmann - La Roche | Managing Partner,munich | Leadership |
Jijimon Augustine | Chief Financial Officer | Leadership |
Josef Moosholzer | Partner Finance | Leadership |
Stefan Fischer | Managing Partner (finance) | Leadership |
Sascha Berger | General Partner,munich | Leadership |
Barbara Hauser | Senior Accountant | Team |
Munich Team | Senior Accountant | Team |
Paul K. | Analyst | Team |
Ivan Shaw | Principal | Team |
Monika Marosevic | Accountant | Team |
Tanja Takides | Senior Accountant,hr And Payroll | Team |
Marie-Claude Marchand | Senior Advisor | Team |
Philipp Lechner | Senior Associate Corporate Finance,munich | Team |
Complete people profiles for TVM Capital Life Science
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TVM Capital Life Science
TVM Capital Life Science has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AMECOGroup and Amecath.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Catheters for dialysis, urology, and central venous uses are contract-manufactured. | amecath.com | Cairo, Egypt | 2001 | Mar 2014 | •••• | |
AMECOGroup is engaged in marketing medical equipment since 1988. | amecogroup.com | Dubai, United Arab Emirates | 1988 | Mar 2014 | •••• |
Complete acquisition details for TVM Capital Life Science
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of TVM Capital Life Science
2 dated milestones of TVM Capital Life Science, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires AMECOGroup.
- Acquisition Acquires Amecath.
Web traffic of TVM Capital Life Science
Websites that share an audience with TVM Capital Life Science (tvm-capital.com).
Websites whose visitors overlap most with TVM Capital Life Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| carlyle.com | 74% | 201.1K | #228,605 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tvm Capital Life Science
Complete news archive for TVM Capital Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TVM Capital Life Science
TVM Capital Life Science is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Funding is provided by TVM Capital Life Science to support novel and disruptive life science innovations. Focus is placed on early-stage therapeutics, commercial-stage medtech, diagnostics, and digital health products. Investments are made to develop and market breakthrough therapies and medical products benefiting patients and the healthcare system. A two-pronged strategy is employed, including financing through single asset companies in partnership with Eli Lilly and Company, and investing in late-stage therapeutics. Close collaboration with portfolio companies is maintained to build value and enable market leadership in their segments.
TVM Capital Life Science offers Venture Capital Investment and Portfolio Company Support.
TVM Capital Life Science has made 2 acquisitions, including AMECOGroup, and Amecath.